Table 5.
SMV/SOF (n=119) |
SMV/SOF/RBV (n=32) |
Total (n=151) |
|
---|---|---|---|
AE Anemia, n (%) | 4 (3.4) | 13 (40.6) | 17 (11.3) |
SAE Anemia, n (%) | 1 (0.8) | 0 (0.0) | 1 (0.7) |
Hemoglobin change, delta mean (range) | −0.1 (−4.9,+3.1) | −1.2 (−6.9,+4.1) | −0.4 (−6.9,+4.1) |
Anemia management, n (%) | |||
Ribavirin dose reduction/interruption | 0 (0.0) | 8 (25.0) | 8 (5.3) |
Epoietin use | 0 (0.0) | 5 (15.6) | 5 (3.3) |
Blood transfusion | 2 (1.7) | 3 (9.4) | 5 (3.3) |
Ribavirin discontinuation | 0 (0.0) | 1 (3.1) | 1 (0.7) |